Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients

Cancer Research

Volumn 56, Issue 12, 1996, Pages 2827-2831

  Yamamoto, Nobuto ^a   Naraparaju, Venkateswara R ^a   Asbell, Sucha O ^b  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; BETA GALACTOSIDASE; MACROPHAGE ACTIVATING FACTOR; VITAMIN D BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; DEGLYCOSYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; INFECTION RISK; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DEGRADATION;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; FEMALE; GLYCOSYLATION; HEXOSAMINIDASES; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; MONOCYTES; NEOPLASMS; PROTEIN PRECURSORS; SUBSTRATE SPECIFICITY; VITAMIN D-BINDING PROTEIN;

EID: 0029920271     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Burnet, M. Immunologic factors in the process of carcinogenesis. Br. Med. Bull., 20: 154-158, 1964.
2. Gross, L Immunological defect in aged population and its relationship to cancer. Cancer Res., 18: 201-204, 1965.
3. Freedman, H., and Ceglowski, W. Immunosuppression in the etiology of cancer. In: L. Baer and G. Santos (eds), Immunological Aspects of Neoplasia, pp. 253-291. Baltimore. Williams & Wilkins Co., 1965.
4. Ngwenya, B. Z., and Yamamoto, N Activation of peritoneal macrophages by lysophosphatidylcholine. Biochim. Biophys. Acta, 839: 9-15, 1985.
5. Ngwenya, B. Z , and Yamamoto, N. Effects of inflammation products on immune systems: lysophosphatidylcholine stimulates macrophages. Cancer Immunol. Immunother., 21. 174-182, 1986.
6. Yamamoto, N., and Ngwenya, B. Z Activation of mouse peritoneal macrophages by lysophospholipids and ether derivatives of neutral lipids and phospholipids. Cancer Res., 47: 2008-2013, 1987.
7. Ngwenya, B. Z., and Yamamoto, N Contribution of lysophosphatidyl-choline-treated nonadherent cells to mechanism of macrophage activation. Proc. Soc. Exp. Biol. Med., 193 118-124, 1990.
8. Yamamoto, N., Ngwenya, B. Z., Sery, T W., and Pieringer, P. A. Activation of macrophages by ether analogues of lysophospholipids. Cancer Immunol. Immunother., 25: 185-192, 1987.
9. 3-binding protein and albumin Infect. Immunity, 61. 5388-5391, 1993.
10. Yamamoto, N., Willett, N. P., and Lindsay, D. D. Participation of serum proteins in the inflammation-pruned activation of macrophages. Inflammation, 18: 311-322, 1994.
11. Homma, S., Yamamoto, M., and Yamamoto, N. Vitamin D binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine. Immunol Cell Biol., 71. 249-257, 1993.
12. 3 binding protein (group-specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages. J. Immunol., 147: 273-280, 1991.
13. 3 binding protein (group-specific component) is a precursor for the macrophage activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc. Natl Acad. Sci. USA, 88: 8539-8543, 1991.
14. 3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of β-galactosidase of B cells and sialidase of T cells. J Immunol. 151, 2794-2802, 1993.
15. Naraparaju, V. R., and Yamamoto, N. Roles of p-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages Immunol. Lett., 43: 143-148, 1994.
16. 3-Sepharose chromatography. Anal. Biochem., 157: 262-269, 1986.
17. Yagi, F., Eckhardt, A. E., and Goldstein, I. J. Glycosidases of Ehrlich ascites tumor cells and ascitic fluid-purification and substrate specificity of α-N-acetylgalactosammidase and α-galactosidase comparison with coffee bean α-galactosidase. Arch. Biochem. Biophys, 280: 61-67, 1990.
18. Wang, A. M , and Desnick, R. J. Structural organization and complete sequence of the human α-N-acetylgalactosaminidase gene, homology with the α-galactosidase A gene provides evidence for evolution from a common ancestral gene. Genomics, 10: 133-142, 1991.
19. Coppenhaver, D. H., Sollenne, N. P., and Bowman, B. H. Post-translational heterogeneity of the human vitamin D-binding protein (group-specific component). Arch. Biochem. Biophys., 226: 218-223, 1983.
20. Viau, M., Constans, J., Debray, H., and Motreuil, J. Isolation and characterization of the O-glycan chain of the human vitamin-D binding protein. Biochem. Biophys. Res Commun., 117: 324-331, 1983.
21. Burnet, F M The concept of immunological surveillance. Prog Exp. Tumor Res., 13: 1-27, 1970
22. 3-binding protein and immunosuppression in AIDS patients AIDS Res Human Retroviruses, 11: 1373-1378, 1995
23. Dalgleish, A. G., Beverly, P. C L., Clapham, P R., Crawford, D. H., Greaves, M. F., and Weiss, R. A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature, 312: 763-767, 1984.
24. Bosmann, H. B., and Bemacki, R J. Glycosidase activity in L51784 mouse leukemic cells and the activity of acid phosphatase, β-galactosidase, β-N-acetylgalactosaminidase, and β-N-acetylglucosaminidase in a synchronous L51784 cell population Exp. Cell Res., 61, 379-386, 1970.
25. Woynarowska, B , Wikiel, H., and Bernacki, R. I. Human ovarian carcinoma β-N-acetylglucosaminidase isozymes and their role in extracellular matrix degradation. Cancer Res., 49: 5598-5604, 1989.
26. Fauve, R. M. Some aspects of the macrophage-cancer relationship. Res. Immunol., 144: 265-268, 1993.
27. 3-binding protein-derived macrophage activating factor on Ehrlich tumor bearing mice Proc. Am. Assoc. Cancer Res., 37: 481, 1996.